Avalo Therapeutics, Inc.·4

Apr 4, 6:25 PM ET

Persson Magnus 4

4 · Avalo Therapeutics, Inc. · Filed Apr 4, 2022

Insider Transaction Report

Form 4
Period: 2022-03-31
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-31+18,46818,468 total
    Exercise: $0.72From: 2022-03-31Exp: 2032-03-31Common Stock (18,468 underlying)
Footnotes (1)
  • [F1]100% of the stock option will immediately vest on the date that it is granted.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT